May 4, 2022 | John Mariani, MD The presenter will explore the promising and best practices on the use of XR Buprenorphine and naltrexone. The ways the medications can be delivered and practical issues of certification in the SUBLOCADE REMS program, storage, and administration will be discussed. Learning objectives: Assess which patients are appropriate for treatment with the extended release (XR) formulation of Buprenorphine and Naltrexone. Familiarize with the induction and monitoring processes for XR Buprenorphine and XR Naltrexone. Familiarize with delivery, storage, and administration (including certification in the Sublocade REMS Program).